The genome sequence of the SARS-associated coronavirus

被引:1585
|
作者
Marra, MA
Jones, SJM
Astell, CR
Holt, RA
Brooks-Wilson, A
Butterfield, YSN
Khattra, J
Asano, JK
Barber, SA
Chan, SY
Cloutier, A
Coughlin, SM
Freeman, D
Girn, N
Griffith, OL
Leach, SR
Mayo, M
McDonald, H
Montgomery, SB
Pandoh, PK
Petrescu, AS
Robertson, AG
Schein, JE
Siddiqui, A
Smailus, DE
Stott, JE
Yang, GS
Plummer, F
Andonov, A
Artsob, H
Bastien, N
Bernard, K
Booth, TF
Bowness, D
Czub, M
Drebot, M
Fernando, L
Flick, R
Garbutt, M
Gray, M
Grolla, A
Jones, S
Feldmann, H
Meyers, A
Kabani, A
Li, Y
Normand, S
Stroher, U
Tipples, GA
Tyler, S
机构
[1] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada
[2] Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada
[3] British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada
[4] Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada
[5] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada
关键词
D O I
10.1126/science.1085953
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We sequenced the 29,751-base genome of the severe acute respiratory syndrome (SARS)-associated coronavirus known as the Tor2 isolate. The genome sequence reveals that this coronavirus is only moderately related to other known coronaviruses, including two human coronaviruses, HCoV-OC43 and HCoV-229E. Phylogenetic analysis of the predicted viral proteins indicates that the virus does not closely resemble any of the three previously known groups of coronaviruses. The genome sequence will aid in the diagnosis of SARS virus infection in humans and potential animal hosts (using polymerase chain reaction and immunological tests), in the development of antivirals (including neutralizing antibodies), and in the identification of putative epitopes for vaccine development.
引用
收藏
页码:1399 / 1404
页数:7
相关论文
共 50 条
  • [21] Structural organization of the genome of SARS-associated coronavirus (strain SoD) isolated on the territory of the Russian Federation
    Onishchenko, GG
    Govorun, VM
    Sergienko, VI
    Akopian, TA
    Momynaliev, KT
    Vereshchagin, VA
    Lazarev, VN
    Vasil'ev, NT
    Markov, VI
    Merkulov, VA
    Maksimov, VA
    Mel'nikov, VA
    Lopukhin, YM
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2004, 137 (02) : 197 - 199
  • [22] Inhibition of SARS-associated coronavirus infection and replication by RNA interference
    He, ML
    Zheng, BJ
    Peng, Y
    Peiris, JSM
    Poon, LLM
    Yuen, KY
    Lin, MCM
    Kung, HF
    Guan, Y
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20): : 2665 - 2666
  • [23] Development and evaluation of the kit for detection of SARS-associated coronavirus RNA
    Shipulin, GA
    Yatsyshina, SB
    Chulanov, VP
    Markelov, MY
    Shipulina, OY
    Podkolzin, AT
    Astakhova, TS
    Shishova, A
    Cao, WC
    Liu, W
    Fan, BC
    TERAPEVTICHESKII ARKHIV, 2004, 76 (04) : 25 - 30
  • [24] Heat sensitivity of a SARS-associated coronavirus introduced into plasma products
    Yunoki, M
    Urayama, T
    Yamamoto, I
    Abe, S
    Ikuta, K
    VOX SANGUINIS, 2004, 87 (04) : 302 - 303
  • [25] Coronaviridae and SARS-associated coronavirus strain HSR1
    Vicenzi, E
    Canducci, F
    Pinna, D
    Mancini, N
    Carletti, S
    Lazzarin, A
    Bordignon, C
    Poli, G
    Clementi, M
    EMERGING INFECTIOUS DISEASES, 2004, 10 (03) : 413 - 418
  • [26] Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS
    Timani, KA
    Ye, L
    Ye, LB
    Zhu, Y
    Wu, ZH
    Gong, ZJ
    JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (04) : 309 - 312
  • [27] Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients
    Wang, YB
    Chang, ZR
    Jing, OY
    Wei, HY
    Yang, RQ
    Chao, YG
    Qu, JG
    Wang, JW
    Hung, T
    DNA AND CELL BIOLOGY, 2005, 24 (08) : 521 - 527
  • [28] A candidate SARS-associated coronavirus vaccine elicits broad immunity in monkeys
    Gao, WT
    Tamin, A
    Soloff, A
    D'Aiuto, L
    Nwanegbo, E
    Robbins, PD
    Bellini, WJ
    Barratt-Boyes, S
    Gambotto, A
    MOLECULAR THERAPY, 2004, 9 : S208 - S208
  • [29] Identification of natural compounds with antiviral activities against SARS-associated coronavirus
    Li, SY
    Chen, C
    Zhang, HQ
    Guo, HY
    Wang, H
    Wang, L
    Zhang, X
    Hua, SN
    Yu, J
    Xiao, PG
    Li, RS
    Tan, XH
    ANTIVIRAL RESEARCH, 2005, 67 (01) : 18 - 23
  • [30] Three critical clinicobiological phases of the human SARS-associated coronavirus infections
    Turk, C.
    Turk, S.
    Malkan, U. Y.
    Haznedaroglu, I. C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (16) : 8606 - 8620